A new Cochrane systematic review found that high dose aspirin can reduce migraine headache within 2 hours.
The review compared the use of aspirin to placebo or other migraine drugs including 13 studies and 4222 patients with migraine attacks. The amount of aspirin used in these studies varied between 900 - 1000 mg. Patients were randomly assigned to either a single dose of aspirin or a placebo or an active drug.
Researchers found that 24% of aspirin users were pain-free within 2 hours comapred to 11% of placebo users, aspirin also reduced the symptoms of nausea and vomiting, but aspirin plus antiemetic reduced these symptoms significantly compared with placebo. They concluded that 1000 mg of aspirin is effective for migraine relief, similar to the effect with sumatriptan.
Critics say that it is important to note that the over-the-counter standard aspirin is only 75mg and evidence has shown that regular use of aspirin may increase stomach problem or bleeding, taking high dose aspirin may increase these side effects. Also the effectiveness of aspirin may not apply to everyone as only a quarter of patients in these studies were pain-free after 2 hours.
Source : Kirthi V, Derry S, Moore RA, McQuay HJ. "Aspirin with or without an antiemetic for acute migraine headaches in adults (Review)". The Cochrane Library 2010, Issue 4
This library blog is an electronic current awareness bulletin for doctors in training to help them stay current with up-to-date health-related research news, useful resources and more!
Showing posts with label migraine. Show all posts
Showing posts with label migraine. Show all posts
Monday, April 26, 2010
Monday, June 11, 2007
Patient with dark green blood
The Lancet reported a team of Canadian surgeons performed urgent procedures on a patient who had developed compartment syndrome, they were shocked when the patient began shedding dark green blood.
In this case, the patient has taken large doses of the migraine medication, sumatriptan, that caused a rare condition called sulfhaemoglobinaemia. The patient recovered and stopped taking sumatriptan after discharge. After 5 weeks, he was found to have no sulfhaemoglobin in his blood.
In this case, the patient has taken large doses of the migraine medication, sumatriptan, that caused a rare condition called sulfhaemoglobinaemia. The patient recovered and stopped taking sumatriptan after discharge. After 5 weeks, he was found to have no sulfhaemoglobin in his blood.
Subscribe to:
Posts (Atom)